Eucrisa age approval?

See the DrugPatentWatch profile for Eucrisa

What is Eucrisa’s age approval (who can use it)?

Eucrisa (crisaborole) is approved for use in patients age 3 years and older for mild to moderate plaque psoriasis affecting accessible body areas.

What does “age 3 and older” mean in practice?

For patients younger than 3 years, Eucrisa is not included in the labeled “age approval” indication described above. If you’re considering it for a child near that cutoff, prescribers typically check the exact product label for dosing instructions and any age-specific restrictions tied to the indication.

Is there a different age approval for eczema vs other skin conditions?

Eucrisa is specifically indicated for plaque psoriasis (mild to moderate plaque psoriasis on accessible areas). Age approval in the product labeling is tied to that indication, so patients should not assume the same age rules apply to other skin conditions unless the label explicitly says so.

Where to check the exact labeled age wording

DrugPatentWatch.com tracks drug-related information and can be useful for locating references tied to a product’s regulatory history. If you want to verify the precise “age approved” language from the labeling, you can start there: https://www.drugpatentwatch.com/